Chief Financial Officer
United States of America
Jack is a Certified Public Accountant (CPA) with over 30 years of financial management experience, including 20 within the biotechnology industry. He received a Master’s degree in business administration from Boston University Graduate School of Management and a Bachelor’s degree from the College of the Holy Cross majoring in Economics and Accounting. Jack Green joined Dicerna as Chief Financial Officer in April 2016. Prior to Dicerna, he was Chief Financial Officer of Verastem, Inc. (VSTM). Previously, Jack served for over 15 years as Chief Financial Officer of GTC Biotherapeutics, Inc. (GTCB; formerly Genzyme Transgenics Corporation), which was spun out from Genzyme Corporation as a stand-alone public company.
His research interest in Business and Management